These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice. Achour M; Le Gras S; Keime C; Parmentier F; Lejeune FX; Boutillier AL; Néri C; Davidson I; Merienne K Hum Mol Genet; 2015 Jun; 24(12):3481-96. PubMed ID: 25784504 [TBL] [Abstract][Full Text] [Related]
3. Single-Nucleus RNA-Seq Reveals Dysregulation of Striatal Cell Identity Due to Huntington's Disease Mutations. Malaiya S; Cortes-Gutierrez M; Herb BR; Coffey SR; Legg SRW; Cantle JP; Colantuoni C; Carroll JB; Ament SA J Neurosci; 2021 Jun; 41(25):5534-5552. PubMed ID: 34011527 [TBL] [Abstract][Full Text] [Related]
4. Enhancer RNAs: a missing regulatory layer in gene transcription. Mao R; Wu Y; Ming Y; Xu Y; Wang S; Chen X; Wang X; Fan Y Sci China Life Sci; 2019 Jul; 62(7):905-912. PubMed ID: 30593613 [TBL] [Abstract][Full Text] [Related]
5. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease. Ma Q; Yang J; Li T; Milner TA; Hempstead BL Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324 [TBL] [Abstract][Full Text] [Related]
6. Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease. Desplats PA; Lambert JR; Thomas EA Neurobiol Dis; 2008 Sep; 31(3):298-308. PubMed ID: 18595722 [TBL] [Abstract][Full Text] [Related]
7. Age-related and disease locus-specific mechanisms contribute to early remodelling of chromatin structure in Huntington's disease mice. Alcalá-Vida R; Seguin J; Lotz C; Molitor AM; Irastorza-Azcarate I; Awada A; Karasu N; Bombardier A; Cosquer B; Skarmeta JLG; Cassel JC; Boutillier AL; Sexton T; Merienne K Nat Commun; 2021 Jan; 12(1):364. PubMed ID: 33441541 [TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease. Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516 [TBL] [Abstract][Full Text] [Related]
9. Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. Desplats PA; Kass KE; Gilmartin T; Stanwood GD; Woodward EL; Head SR; Sutcliffe JG; Thomas EA J Neurochem; 2006 Feb; 96(3):743-57. PubMed ID: 16405510 [TBL] [Abstract][Full Text] [Related]
10. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement. Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241 [TBL] [Abstract][Full Text] [Related]
11. Enhancer RNAs step forward: new insights into enhancer function. Harrison LJ; Bose D Development; 2022 Aug; 149(16):. PubMed ID: 36039999 [TBL] [Abstract][Full Text] [Related]
12. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease. Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156 [TBL] [Abstract][Full Text] [Related]
13. Non-coding RNA derived from the region adjacent to the human HO-1 E2 enhancer selectively regulates HO-1 gene induction by modulating Pol II binding. Maruyama A; Mimura J; Itoh K Nucleic Acids Res; 2014 Dec; 42(22):13599-614. PubMed ID: 25404134 [TBL] [Abstract][Full Text] [Related]
14. Integrator mediates the biogenesis of enhancer RNAs. Lai F; Gardini A; Zhang A; Shiekhattar R Nature; 2015 Sep; 525(7569):399-403. PubMed ID: 26308897 [TBL] [Abstract][Full Text] [Related]
16. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice. Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease. McFarland KN; Das S; Sun TT; Leyfer D; Kim MO; Xia E; Sangrey GR; Kuhn A; Luthi-Carter R; Clark TW; Sadri-Vakili G; Cha JH J Huntingtons Dis; 2013; 2(3):263-77. PubMed ID: 25062675 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of enhancer RNA in gene regulation across 12 mouse tissues. Cheng JH; Pan DZ; Tsai ZT; Tsai HK Sci Rep; 2015 Jul; 5():12648. PubMed ID: 26219400 [TBL] [Abstract][Full Text] [Related]
19. Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes. Blinka S; Reimer MH; Pulakanti K; Rao S Cell Rep; 2016 Sep; 17(1):19-28. PubMed ID: 27681417 [TBL] [Abstract][Full Text] [Related]
20. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs. Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]